Ligand Pharmaceuticals (LGND) Net Cash Flow Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 198.34% |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 467.41% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -14,223.53% |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 453.08% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -125.22% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 53.46% |
| 10 | Ligand Pharmaceuticals | 4.61 Bn | 3.83 Bn | 48.45 Mn | -136.34% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -136.34% |
| Dec 31, 2025 | 253.08% |
| Sep 30, 2025 | 53.63% |
| Jun 30, 2025 | 162.99% |
| Mar 31, 2025 | -193.22% |
| Dec 31, 2024 | 230.62% |
| Sep 30, 2024 | 625.25% |
| Jun 30, 2024 | 46.99% |
| Mar 31, 2024 | -37.93% |
| Dec 31, 2023 | -92.43% |
| Sep 30, 2023 | -637.71% |
| Jun 30, 2023 | -520.64% |
| Mar 31, 2023 | 1,065.38% |
| Dec 31, 2022 | 1,146.58% |
| Sep 30, 2022 | -181.80% |
| Jun 30, 2022 | 4.68% |
| Mar 31, 2022 | 71.27% |
| Dec 31, 2021 | 99.05% |
| Sep 30, 2021 | -99.58% |
| Jun 30, 2021 | -328.15% |
| Mar 31, 2021 | -134.16% |
| Dec 31, 2020 | -165.35% |
| Sep 30, 2020 | 810.76% |
| Jun 30, 2020 | -100.87% |
| Mar 31, 2020 | 468.02% |
| Dec 31, 2019 | -293.29% |
| Sep 30, 2019 | -719.49% |
| Jun 30, 2019 | 173.81% |
| Mar 31, 2019 | -141.25% |
| Dec 31, 2018 | -223.55% |
| Sep 30, 2018 | 128.19% |
| Jun 30, 2018 | 102.56% |
| Mar 31, 2018 | 474.85% |
| Dec 31, 2017 | 82.13% |
| Sep 30, 2017 | -208.93% |
| Jun 30, 2017 | 64.96% |
| Mar 31, 2017 | 87.74% |
| Dec 31, 2016 | -1,954.24% |
| Sep 30, 2016 | 274.38% |
| Jun 30, 2016 | 152.25% |
| Mar 31, 2016 | -1,288.84% |
| Dec 31, 2015 | 117.88% |
| Sep 30, 2015 | -108.71% |
| Jun 30, 2015 | -3,790.06% |
| Mar 31, 2015 | 315.77% |
| Dec 31, 2014 | -344.50% |
| Sep 30, 2014 | 6,364.22% |
| Jun 30, 2014 | 75.96% |
| Mar 31, 2014 | 118.22% |
| Dec 31, 2013 | 74.88% |
| Sep 30, 2013 | -78.11% |
| Jun 30, 2013 | 228.03% |
| Mar 31, 2013 | -368.42% |
| Dec 31, 2012 | -0.10% |
| Sep 30, 2012 | -25.13% |
| Jun 30, 2012 | 73.30% |
| Mar 31, 2012 | 1.82% |
| Dec 31, 2011 | 2,647.87% |
| Sep 30, 2011 | -311.74% |